EC approves DuoPlavin/DuoCover

The European Commission approved an MAA from Bristol-Myers Squibb Co. (NYSE:BMY) and sanofi-aventis Group (Euronext:SAN; NYSE:SNY) for DuoPlavin/ DuoCover to prevent atherothrombotic events in patient...